
Loading, please wait...

Loading, please wait...

The ACT TBM randomized trial evaluated whether adding aspirin or clopidogrel to standard antituberculous treatment could reduce clinical stroke or MRI-detected cerebral infarction in tuberculous meningitis. Two hundred and thirty-seven patients were randomised to aspirin, clopidogrel or standard therapy, with MRI and vascular imaging performed during follow-up. At one and three months, there was no significant difference between groups in clinical stroke, imaging-based infarction, mortality or functional outcome. Major bleeding was uncommon and occurred in two patients overall. The findings are important because earlier smaller studies had suggested that aspirin might reduce vascular complications in TB meningitis. ACT TBM provides larger, contemporary evidence against assuming a routine clinical benefit from adjunctive antiplatelet therapy. For HCPs, standard anti-tuberculous therapy and corticosteroid management remain the foundation of care, while cerebral infarction and vasculopathy require careful neurological and imaging assessment. The study is particularly relevant to IANCON's dedicated neuroinfection programme and its emphasis on tuberculous meningitis and neurological complications.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The ACT TBM randomized trial evaluated whether adding aspirin or clopidogrel to standard antituberculous treatment could reduce clinical stroke or MRI-detected cerebral infarction in tuberculous meningitis. Two hundred and thirty-seven patients were randomised to aspirin, clopidogrel or standard therapy, with MRI and vascular imaging performed during follow-up. At one and three months, there was no significant difference between groups in clinical stroke, imaging-based infarction, mortality or functional outcome. Major bleeding was uncommon and occurred in two patients overall. The findings are important because earlier smaller studies had suggested that aspirin might reduce vascular complications in TB meningitis. ACT TBM provides larger, contemporary evidence against assuming a routine clinical benefit from adjunctive antiplatelet therapy. For HCPs, standard anti-tuberculous therapy and corticosteroid management remain the foundation of care, while cerebral infarction and vasculopathy require careful neurological and imaging assessment. The study is particularly relevant to IANCON's dedicated neuroinfection programme and its emphasis on tuberculous meningitis and neurological complications.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back